-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HfDsBTX5/BKj+5QX3tCE6L6cuMbHlmkkfzQnT8dUGuTuNJebfQjSHTkHvTnstwKZ CIckHvOVdya1eUajKVVUqw== 0000904454-98-000049.txt : 19980212 0000904454-98-000049.hdr.sgml : 19980212 ACCESSION NUMBER: 0000904454-98-000049 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980211 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN ONCOLOGY RESOURCES INC /DE/ CENTRAL INDEX KEY: 0000943061 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 841213501 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-49269 FILM NUMBER: 98530478 BUSINESS ADDRESS: STREET 1: 16825 NORTHCHASE DR STREET 2: STE 1300 CITY: HOUSTON STATE: TX ZIP: 77060 BUSINESS PHONE: 7188732674 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELSH CARSON ANDERSON & STOWE V LP CENTRAL INDEX KEY: 0000902672 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 MAIL ADDRESS: STREET 1: 320 PARK AVENUE STREET 2: SUITE 2500 CITY: NEW YORK STATE: NY ZIP: 10022 SC 13G 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ SCHEDULE 13G Information Statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Final Amendment) American Oncology Resources, Inc. _________________________________________________________________ (Name of Issuer) Common Stock, $.01 par value _________________________________________________________________ (Title of Class of Securities) 028910107 _________________________________________________________________ (CUSIP Number) ______________________________ CUSIP No. 028910107 Page 2 of 5 Pages _________________________________________________________________ 1) Name of Reporting Person Welsh, Carson, S.S. or I.R.S. Identification Anderson & Stowe No. of Above Person V, L.P. _________________________________________________________________ 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] _________________________________________________________________ 3) SEC Use Only _________________________________________________________________ 4) Citizenship or Place Delaware of Organization _________________________________________________________________ Number of Shares 5) Sole Voting 1,452,154 shares of Beneficially Power Common Stock, $.01 Owned by Each par value ("Common Reporting Person Stock") With: ________________________________________ 6) Shared Voting Power -0- ________________________________________ 7) Sole Disposi- 1,452,154 shares of tive Power Common Stock ________________________________________ 8) Shared Dis- positive Power -0- ________________________________________ 9) Aggregate Amount Beneficially 1,452,154 shares of Owned by Each Reporting Person Common Stock _________________________________________________________________ 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares _________________________________________________________________ 11) Percent of Class Represented by 4.9% Amount in Row (9) _________________________________________________________________ 12) Type of Reporting Person PN CUSIP No. 028910107 Page 3 of 5 Pages _________________________________________________________________ 1) Name of Reporting Person WCAS Healthcare S.S. or I.R.S. Identification Partners, L.P. No. of Above Person _________________________________________________________________ 2) Check the Appropriate Box (a) [ X ] if a Member of a Group (b) [ ] _________________________________________________________________ 3) SEC Use Only _________________________________________________________________ 4) Citizenship or Place Delaware of Organization _________________________________________________________________ Number of Shares 5) Sole Voting -0- Beneficially Power Owned by Each Reporting Person With: ________________________________________ 6) Shared Voting Power -0- ________________________________________ 7) Sole Disposi- -0- tive Power ________________________________________ 8) Shared Dis- positive Power -0- ________________________________________ 9) Aggregate Amount Beneficially -0- Owned by Each Reporting Person _________________________________________________________________ 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares _________________________________________________________________ 11) Percent of Class Represented by -0- Amount in Row (9) _________________________________________________________________ 12) Type of Reporting Person PN CUSIP No. 028910107 Page 4 of 5 Pages Final Amendment to Schedule 13G _______________________________ Reference is hereby made to the statement on Schedule 13G originally filed with the Securities and Exchange Commission on January 29, 1996 and Amendment No. 1 thereto filed on February 12, 1997 (as so amended, the "Schedule 13G"). Terms defined in the Schedule 13G are used herein as so defined. The Schedule 13G is hereby amended as follows: Item 1(b) - Address of Issuer's Principal Executive Offices: 16825 Northchase Drive, Suite 1300 Houston, TX 77060 Item 4 - Ownership. (a) Amount Beneficially Owned: WCAS V: 1,452,154 shares of Common Stock Healthcare Partners: -0- (b) Percent of Class: WCAS V: 4.9% Healthcare Partners: -0- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: WCAS V: 1,452,154 Healthcare Partners: -0- (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: WCAS V: 1,452,154 Healthcare Partners: -0- (iv) shared power to dispose or to direct the disposition of: -0- Item 5 - Ownership of Five Percent or Less of a Class: This statement is being filed to report that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock. CUSIP No. 028910107 Page 5 of 5 Pages Signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. WELSH, CARSON, ANDERSON & STOWE V, L.P. By: WCAS V Partners, General Partner By /s/ Laura VanBuren General Partner WCAS HEALTHCARE PARTNERS, L.P. By: WCAS HP Partners, General Partner By /s/ Russell L. Carson General Partner Dated: February 10, 1998 -----END PRIVACY-ENHANCED MESSAGE-----